Asuka Corp Sees Strong Q1 Performance Amid Auto Parts Growth, Margin Pressure Lingers
Asuka Corp (TSE:7227), a Japanese manufacturer specializing in automotive components, electrical distribution panels, and robotics systems, reported a
Earnings
Company WHOM (TSE:2341) FY2026 Analysis: Guidance Points to Accelerating Growth
Company WHOM (TSE:2341), a leading publisher of free job listing magazines in Japan with a dominant market position in Shizuoka Prefecture, has delivered
Fujipremium Corporation FY2024 Analysis: Guidance Points to Strong V-Shaped Recovery
Fujipremium (TSE:4237) Corporation FY2024 Analysis: Guidance Points to Strong V-Shaped Recovery
Kojima Co.,Ltd. FY2026 Analysis: Guidance Points to Accelerating Growth
Kojima (TSE:7513) Co.,Ltd. , a mid-sized regional electronics retailer operating under the Big Camera umbrella, reported a modest but positive full-year
Media Five FY2026 Q3 Analysis: Operating Profit Surges Amid Revenue Growth, But Net Profit Slips
Media Five Inc. (TSE:3824), a Japanese IT services provider specializing in technical staffing, business support, and software development, reported a
Takara & Company Ltd. Maintains Strong Margins Amid Revenue Growth in Q3 2026
Takara & Company Ltd. (TSE:7921), a leading provider of disclosure services and a growing player in translation and interpretation, reported a 6.1%
Naito & Co. Ltd. Maintains Revenue Amid Profit Pressure as Strategic Shifts Take Shape
Naito & Co., Ltd. (TSE:7624) reported FY2026 revenue of ¥43.5bn (-0.1% YoY) with operating profit falling 13.1% to ¥403mn, as cost pressures outpaced stable top-line performance in the machinery distribution sector.
Y's Table Corporation Lifts FY2026 Forecast on Margin Recovery and Strategic Expansion
Y's Table Corporation (TSE:2798), a leading operator of restaurants and bars in Japan, reported a strong full-year performance for the 2026 fiscal year
GMO internet group Reports FY2025 Full-Year Results — Operating Profit +19.5%, Dividend Raised to JPY 52
GMO internet group (TSE:9449) reported FY2025 full-year results under its first year of IFRS adoption: revenue ¥285.3bn (+3.3%), operating profit ¥59.1bn (+19.5%), parent net profit ¥16.7bn (+12.8%), and annual dividend raised to JPY 52.00 (+24.4%).
Pharmarise Holdings Posts Sharp Operating Profit Surge Amid M&A Expansion
Pharmarise Holdings Corporation (TSE:2796) reported a significant increase in operating profit for the third quarter of its fiscal year, driven by M&A